Detalhe da pesquisa
1.
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors.
Br J Cancer
; 129(2): 309-317, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237172
2.
Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).
Ann Surg Oncol
; 30(3): 1354-1363, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36622529
3.
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 23(1): 77-90, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914889
4.
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade.
Br J Cancer
; 126(4): 569-575, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34621044
5.
Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child-Pugh B liver function at study week 8: a retrospective analysis of the CELESTIAL randomised controlled trial.
BMC Cancer
; 22(1): 377, 2022 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35397508
6.
CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis.
J Hepatol
; 75(3): 600-609, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051329
7.
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.
N Engl J Med
; 379(1): 54-63, 2018 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29972759
8.
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Lancet Oncol
; 21(6): 796-807, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32416072
9.
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.
Lancet
; 389(10088): 2492-2502, 2017 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28434648
10.
ASO Visual Abstract: Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers - Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).
Ann Surg Oncol
; 30(3): 1364-1365, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36542251
11.
A phase 1, dose-escalation study of PF-06664178, an anti-Trop-2/Aur0101 antibody-drug conjugate in patients with advanced or metastatic solid tumors.
Invest New Drugs
; 36(5): 836-847, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29333575
12.
A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours.
Invest New Drugs
; 36(6): 1026-1036, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29637471
13.
Liver Cancer Immunity.
Hepatology
; 73 Suppl 1: 86-103, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32516437
14.
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
JAMA
; 317(23): 2392-2401, 2017 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28632865
15.
A phase II trial of bevacizumab plus temsirolimus in patients with advanced hepatocellular carcinoma.
Invest New Drugs
; 33(1): 241-6, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25318437
16.
Single nucleotide polymorphisms in AREG and EREG are prognostic biomarkers in locally advanced gastric cancer patients after surgery with curative intent.
Pharmacogenet Genomics
; 24(11): 539-47, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25203737
17.
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma.
Cancer Res Commun
; 4(3): 682-690, 2024 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38363156
18.
Exposure-response analysis for nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040).
Clin Transl Sci
; 16(8): 1445-1457, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37165980
19.
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial.
J Clin Oncol
; 41(9): 1747-1757, 2023 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36512738
20.
SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma.
Invest New Drugs
; 30(4): 1646-51, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21748296